[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100615462":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":37,"responsibleParty":55,"collaborators":58,"id":61,"slug":12,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":12,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":12,"enrollmentInfo":69,"targetDuration":12,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":40,"whyStopped":12,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":89},{"fullName":5,"class":6},"Hong Kong Metropolitan University","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Waitlist Control Group","NO_INTERVENTION","The waitlist control group will not receive any intervention within the study period",null,{"label":14,"type":15,"description":16,"interventionNames":17},"d-MFT Intervention Group","EXPERIMENTAL","The d-MFT intervention group will participate in a 3-month digital-support Myofunctional Therapy program. This innovative program is designed to ensure proper exercise performance, enhance adherence, and provide real-time feedback to patients.",[18],"Behavioral: Digital-supported Orofacial Myofunctional Therapy",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":12},"BEHAVIORAL","Digital-supported Orofacial Myofunctional Therapy","The intervention include: (1) Five 30-minute d-MFT sessions; (2) two follow-up phone calls; and (3) facial and tongue exercise app for home practice.",[14],[26],{"name":27,"affiliation":5,"role":28},"Agnes YK Lai, PhD","PRINCIPAL_INVESTIGATOR",[30,34],{"name":27,"role":31,"phone":32,"phoneExt":12,"email":33},"CONTACT","(852)3970-2917","ayklai@hkmu.edu.hk",{"name":35,"role":31,"phone":32,"phoneExt":12,"email":36},"George OC Cheung, MSc","occheung@hkmu.edu.hk",[38],{"facility":39,"status":40,"city":41,"state":41,"zip":12,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Queen Mary Hopsital","RECRUITING","Hong Kong",{"type":43,"coordinates":44},"Point",[45,46],114.17469,22.27832,{"lat":46,"lon":45},[49,52],{"name":50,"role":31,"phone":51,"phoneExt":12,"email":33},"Agnes Lai, PhD","91634839",{"name":53,"role":31,"phone":54,"phoneExt":12,"email":36},"George OC Cheung, MPhil","39702917",{"type":28,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Dr Agnes LAI Yuen Kwan","Associate Professor",[59],{"name":60,"class":6},"Queen Mary Hospital, Hong Kong","100615462",false,"NCT07292922","Digital-supported Orofacial Myofunctional Therapy in OSA","Digital-supported Orofacial Myofunctional Therapy in Subjects With Obstructive Sleep Apnoea: A Pilot Randomised Control Trial","Inclusion Criteria:\n\n* Adults aged 18 years and above\n* Diagnosed with mild to moderate Obstructive Sleep Apnoea, defined as: Apnoea-Hypopnea Index of 5-30 events per hour\n* Indications for Continuous Positive Airway Pressure or oral appliance treatment, but unable to tolerate or decline these treatments\n* Body Mass Index less than 30 kg\u002Fm2\n\nExclusion Criteria:\n\n* Presence of obstructive nasal disease or significant nasal obstruction\n* Unstable mental health issues\n* History of stroke\n* Unstable chronic respiratory, cardiac, neurological conditions\n* Inability to provide informed consent\n* Prior oral, pharyngeal, or maxillofacial surgical therapy for sleep apnoea","ALL","18 Years",{"count":70,"type":71},60,"ESTIMATED","INTERVENTIONAL",[74],"NA","This pilot study explores the feasibility, acceptability, and preliminary effectiveness of Digital-supported Orofacial Myofunctional Therapy (d-MFT), an innovative program combining facial recognition technology with evidence-based orofacial exercises for individuals with mild to moderate obstructive sleep apnoea (OSA). The d-MFT program aims to strengthen oropharyngeal muscles, improve airway function, and reduce OSA severity.\n\nParticipants receiving 3-month d-MFT (n=30) are expected to demonstrate greater improvements in OSA severity, sleep-related symptoms, and quality of life compared to those in the waitlist control group (n=30).\n\nFeasibility and acceptability will be evaluated through outcome-based questionnaires and semi-structured interviews to explore participants' experiences, satisfaction, and perceived barriers to adherence.",[77],"Obstructive Sleep Apnea (OSA)",[79],"Orofacial Myofunctional Therapy","2026-03-11",{"date":82,"type":83},"2026-03-13","ACTUAL",{"date":85,"type":83},"2026-01-05",{"date":87,"type":71},"2027-04-30",{"name":5,"class":6},1]